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Transduction by BB-1, a Bacteriophage of Borrelia burgdorferi
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We previously described a bacteriophage of the Lyme disease agent Borrelia burgdorferi designated BB-1.
This phage packages the host complement of the 32-kb circular plasmids (cp32s), a group of homologous
molecules found throughout the genus Borrelia. To demonstrate the ability of BB-1 to package and transduce
DNA, a kanamycin resistance cassette was inserted into a cloned fragment of phage DNA, and the resulting
construct was transformed into B. burgdorferi CA-11.2A cells. The kan cassette recombined into a resident cp32
and was stably maintained. The cp32 containing the kan cassette was packaged by BB-1 released from this
B. burgdorferi strain. BB-1 has been used to transduce this antibiotic resistance marker into naive CA-11.2A
cells, as well as two other strains of B. burgdorferi. This is the first direct evidence of a mechanism for lateral
gene transfer in B. burgdorferi.
Borrelia burgdorferi, the causative agent of Lyme disease
(5, 32), has a complex genome that contains both linear and
circular DNA (7, 13). A growing number of tools have been
developed for studying the molecular biology of this organism,
although elaborating a convenient manipulatable genetic system will require further effort. Despite indirect evidence for
lateral gene transfer in these bacteria (19, 33, 38), natural
mechanisms for the transfer of genetic material (including
conjugative plasmids and transducing bacteriophages) remain
elusive for B. burgdorferi and related spirochetes.
In a number of other bacteria, bacteriophages are well characterized, naturally occurring mechanisms for lateral gene
transfer (22). Bacteriophages have been observed in association with many spirochetes (reviewed in references 10 and 11),
including Borrelia spp. (3, 12, 14, 23), Leptospira biflexa (29),
and Brachyspira hyodysenteriae (15, 27). VSH-1, a generalized
transducing phage of B. hyodysenteriae, has been used to demonstrate the transfer of antibiotic resistance markers between
two different strains of this spirochete (16). Recently, a prophage from L. biflexa was developed into a shuttle vector (28).
To our knowledge, no transduction or any other naturally
occurring mechanism for the introduction of exogenous DNA
has been demonstrated in B. burgdorferi or related species.
We previously reported the preliminary characterization of a
temperate bacteriophage (Fig. 1) (10–12), designated BB-1,
which packages the 32-kb circular plasmids (cp32s) of the
B. burgdorferi genome. The cp32s are a family of extrachromo-

somal elements, several of which can be maintained in a single
cell (7, 8, 35). There are three regions of variability on these
homologous plasmids: two that encode various lipoproteins,
and one that may encompass a possible partitioning region (1,
6–8, 17, 24, 25, 33–36, 40, 42). Sequence analysis of these
molecules suggests that they have evolutionarily undergone
recombination, possibly from both endogenous and exogenous
sources (6–8, 20, 33, 35, 38). Many features of the cp32 family
are consistent with the hypothesis that these plasmids are temperate prophage genomes (7–11).
To elucidate a possible biological role for BB-1 as well as
evaluate its use as a potential molecular tool, we have extended our characterization of this phage. Using a DNA fragment
from a partial library of BB-1 DNA, we have constructed a
recombinant cp32 (BB-1 prophage) carrying a kanamycin
resistance cassette. Subsequently, BB-1 was used to transduce this recombinant cp32 to other strains of B. burgdorferi.
The introduction of an antibiotic resistance marker into naive
cells by BB-1 is the first direct demonstration of lateral gene
transfer in B. burgdorferi.
MATERIALS AND METHODS
Bacterial strains and bacteriophage recovery. B. burgdorferi sensu stricto
strains CA-11.2A (21) and high-passage B31-UM were part of our collection.
High-passage B. burgdorferi sensu stricto strain 1A7, a clone of Sh2–82, was
generously provided by Tom Schwan (Rocky Mountain Laboratories). Bacterial
isolates were routinely cultivated in modified Barbour-Stoenner-Kelly (BSK-H)
complete medium (Sigma, St. Louis, Mo.) at 34°C with a 5% CO2 atmosphere.
Culture densities were determined, and BB-1 particles were recovered from
cultures induced with 1-methyl-3-nitro-1-nitrosoguanidine(MNNG) as described
previously (12). Phage particles were concentrated, stained, and visualized by
transmission electron microscopy using a protocol described elsewhere (10).
Agarose gel electrophoresis. DNA for restriction digests was extracted as
described previously (12) and digested with different restriction enzymes as
instructed by the manufacturer (New England Biolabs, Beverly, Mass.). DNA
samples were resolved in 0.8% agarose gels (SeaKem GTG; Bio*Whittaker
Molecular Applications; Walkersville, Md.) in TBE (45 mM Tris-borate, 2 mM
EDTA) at 80 V (4.3 V cm⫺1). Field-inversion gel electrophoresis (FIGE) was
performed at room temperature using a PPI-200 programmable power inverter
(MJ Research, Waltham, Mass.) with optimal programs and times for separating
the desired range of fragments determined using the GelTimes software supplied
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FIG. 1. B. burgdorferi phage particles. Samples were collected
from polyethylene glycol-precipitated cell supernatants of an MNNGtreated culture of B. burgdorferi CA-11.2A and viewed by transmission
electron microscopy. Although previously reported as having a simple
noncontractile tail (12), subsequent modifications to the purification
and preparation protocol (10, 11) reveal that all phage particles observed have intact contractile sheaths, seen here either extended (left)
or contracted (right). Phosphotungstic acid stain. Bar, 45 nm.
by the manufacturer. The running buffer was supplemented with 100 mM glycine
(as suggested by MJ Research), and the buffer was recirculated during electrophoresis. After electrophoresis, gels were stained with 0.5 g of ethidium bromide (EtBr) ml⫺1 for 0.5 to 1 h and destained in water for 1 to 2 h. The DNA
was visualized on a UV transilluminator, and images were captured on a Gel Doc
1000 system (Bio-Rad, Hercules, Calif.). Two-dimensional gel electrophoresis
and genomic DNA extraction were performed essentially as described previously
(12, 31).
Southern hybridization. Agarose gels to be blotted were prepared and run as
described above. After visualization, the gels were destained in water and then
vacuum blotted to Immobilon-Ny⫹ (Millipore, Bedford, Mass.) as described
elsewhere (18). Southern hybridization was performed as previously described
(12). Approximate sizes of the major fragments were determined by comparison
to markers of known sizes. Blots to be reprobed were stripped in increasingly
stringent solutions as described elsewhere (2).
The conserved cp32-specific probes used for Southern hybridizations were
probe 4 (8) and a probe that flanks an NdeI site (cp32SK12NdeI) in the paralogous family (PF) gene 50. Probes were generated from B. burgdorferi genomic
DNA by PCR with Taq polymerase as described by the manufacturer (Sigma)
using an annealing temperature of either 50°C (probe 4) or 44°C (probe
cp32SK12NdeI). Additionally, the pOK12 plasmid was used as a probe for the
kan cassette. All probes were labeled using the Prime-it II kit as instructed by the
manufacturer (Stratagene, La Jolla, Calif.).
Variable region PCR. A ClustalW alignment (MacVector 6.5.1; Oxford Molecular, Madison, Wis.) of the available B. burgdorferi B31 cp32 sequences from
GenBank (7) was performed to identify possible diagnostic variable regions.
Oligonucleotides to highly conserved sequences flanking one variable region,
designated VR1, were designed using MacVector (Table 1). The VR1s were
amplified from either cellular cp32s or phage DNA using Taq polymerase and
the cp32-VR1 primers with 25 cycles of 92°C for 1 min, 50°C for 1 min, and 72°C
for 3 min. The PCR products were resolved on 0.8% agarose gels subjected to
FIGE, as described above. The PPI-200 power inverter was programmed with a
maximum resolution in the range of 2 to 6 kb. The sizes of the amplified VR1s
were determined using Multi-Analyst Software 1.0 (Bio-Rad).
Construction of pCE210. HindIII-digested BB-1 DNA was ligated into the
HindIII site of pBluescript II SK⫹ (Stratagene, La Jolla, Calif.), generating a
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library that contained random phage DNA fragments of less than or equal to 4
kb. A plasmid with a 4-kb insert was selected and designated pCE100. The insert
was found to contain one NdeI site approximately 1.1 kb from one end (Fig. 2A).
The 1.3-kb flg promoter-kan fusion conferring kanamycin resistance in B. burgdorferi was excised from pTAKanG (4) by EcoRI digestion. Both pCE100 linearized by digestion with NdeI and the purified kan cassette were treated with
mung bean nuclease (New England Biolabs) to blunt the ends of the DNA as
instructed by the manufacturer. The kan cassette was subsequently ligated into
pCE100, resulting in pCE210 (Fig. 2A).
Transformation of B. burgdorferi CA-11.2A with the kan cassette. pCE210 was
digested with BssHII, and the insert containing the recombinant BB-1 DNAkan cassette was gel purified with a Qiaex gel extraction kit (Qiagen, Valencia,
Calif.). Purified insert DNA (10 l, ⬃2 g) was electroporated into competent
B. burgdorferi CA-11.2A cells and plated in solid medium as described previously
(30). Transformants were selected in solid BSK at 34°C in the presence of 500 g
of kanamycin per ml. Colonies were screened by PCR using the cp32SK12NdeI
primers (Table 1 and Fig. 2) as described above. PCR products were resolved on
1% agarose gels and stained with GelStar nucleic acid stain (Bio*Whittaker
Molecular Applications).
Transduction assays. Phage particles were purified from the cell supernatants
of the CA-11.2A/kanR transformant (12) and treated with an additional 10%
chloroform (CHCl3) to eliminate possible cellular contamination, incubated at
room temperature for 15 min, and then centrifuged at 14,000 ⫻ g, and the
aqueous phase was recovered. Sterile 1 M MgCl2 was added to the sample to
bring the final Mg2⫹ concentration to 16 mM, and 1 l of RQ1 DNase (Promega,
Madison, Wis.) was added per 250 l of volume. After 0.5 h at 37°C, 100 l of
the prepared phage sample (⬃35 ng of phage DNA; the equivalent of ⬃109
phage) was mixed with 107 cells (100:1), and BSK-complete was added for a final
volume of 1 ml.
After 16 h of incubation at 34°C, the phage-cell mixtures were plated, and
potential transductants were selected on solid medium with 500 g of kanamycin
per ml. Colonies were picked and screened by PCR with the cp32SK12NdeIF
and KanR1207F primers (Table 1 and Fig. 2A) using the same parameters as for
the cp32SK12NdeI primer pair. Positive clones were transferred into 10 ml of
BSK-complete with 500 g of kanamycin per ml. The frequency of transduction
was determined as the number of positive transductants divided by the total
number of CFU.
When the putative transductants reached approximately 5 ⫻ 107 cells ml⫺1,
DNA was extracted from the culture and the clones were screened again by
PCR for the kan cassette using the above primers. Additionally, using the
KanR1207F primer and the cp32-VR1R primer, a 7.5-kb region of DNA was
amplified (25 cycles of 92°C for 30 s, 50°C for 30 s, and 72°C for 6 min) with
TaqPlus long (Stratagene) from each transductant.
Analysis of recombinants. Plasmid DNA was extracted from log-phase cultures of B. burgdorferi using Wizard Plus Midi preps (Promega). The concentration of DNA was determined by measuring the absorbance at 260 nm. A total of
500 ng of DNA was digested with either EcoRV or XbaI, and the DNA was
resolved by FIGE. Following electrophoresis and staining, the gels were vacuum
blotted, probed, stripped, and reprobed as described above.

RESULTS
Determining the minimum number of cp32s present in a
population of cells or phage. Specific probes to individual
B. burgdorferi B31 cp32s (8) did not hybridize to B. burgdorferi
CA-11.2A cp32s (data not shown). To determine an approximate number of cp32s in both B. burgdorferi cells and BB-1
capsids, oligonucleotides that flank a diagnostic variable region
(designated VR1) were designed (Table 1). VR1 encompasses
TABLE 1. Oligonucleotides generated for this study
Oligonucleotide

Sequence (5⬘ to 3⬘)

Application

cp32-VR1F
cp32-VR1R
cp32SK12NdeIF
cp32SK12NdeIR
KanR1207F

AAATAAAACTTAGGAGTTGGTTTTGAA
TAACTTTCCTAGCGTTAACTTCTGAT
ACTTTGTTGTAGTGATTATTTGTTC
GGGGAAAGAATTGTTGAAG
ATTACGCTGACTTGACGGG

Diagnostic PCR
Diagnostic PCR
Screening; probe
Screening; probe
kan cassette
screening
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FIG. 2. Kanamycin-resistant transformants of B. burgdorferi. (A) pCE210 construct. A 4-kb fragment of phage DNA (solid line) was cloned into
the HindIII site of pBluescript SK⫹ (dashed line). The kan cassette (hatched box) was cloned into a unique NdeI site on the phage fragment 1.1
kb from the SK primer location. The locations of the SK, KS, cp32SK12NdeIF (cp32F), cp32SK12NdeIR (cp32R), and KanR1207F (kanF)
oligonucleotides are shown (not drawn to scale). Arrows indicate oligonucleotide site and orientation. (B) Transformed CA-11.2A colonies were
screened by PCR using the cp32SK12NdeI primers. PCR products were resolved on a 1% agarose gel and stained with EtBr. Both a small product
(no kan cassette; black arrow) and a larger product (integrated kan cassette; hatched arrow) were amplified from the transformants. (C) Products
consistent with a population of cp32s both containing the kan cassette (hatched arrow) and lacking the kan cassette (black arrow) were also
amplified from phage DNA collected from CA-11.2A/kanR transformants. pCE210 DNA was amplified as a positive (⫹) control, and wild-type
CA-11.2A phage DNA was used as a negative (⫺) control.

a portion of each cp32 where the ospE/ospF/elp genes (erp loci)
are located (1, 6, 7, 20, 25, 35). The cp32-VR1R primer (27
nucleotides) is conserved on all the B. burgdorferi B31 cp32s
and the cp32-like molecule integrated into lp56 (7). The cp32VR1F primer (26 nucleotides) has one mismatch on cp32–9
and two mismatches on the cp32-like molecule integrated into
lp56, but is conserved on all the other B31 cp32s. PCR amplification of VR1 with these oligonucleotides generates products
of different sizes for several of the B. burgdorferi B31 cp32s
whose sequences are available (Table 2).
Using the cp32-VR1 primers and FIGE for maximum resolution, we identified a minimum of four different cp32s and
homologous molecules (i.e., lp56) present in B. burgdorferi
CA-11.2A (Table 3; Fig. 3, lane 1) and also a minimum of four
different cp32s (or homologous molecules) present in B. burgdorferi strain B31-UM (Table 3; Fig. 3, lane 3). The BB-1

phages released from CA-11.2A (Fig. 3, lane 2) and B31 cells
(Fig. 3, lane 4) package cp32s that are represented by only
three of the VR1s amplified from the respective hosts. The
absence of the ⬃2.8-kb band (Table 3) from both BB-1 samples suggests that the phage does not package the cp32 that is
integrated into lp56 (or any DNA that is packaged from the
lp56 does not include the targeted region).
Inserting the kanamycin resistance cassette into a cp32. A
construct containing a 1.3-kb kan gene integrated into a fragment of phage DNA (see Fig. 2A) was transformed into
B. burgdorferi CA-11.2A cells. Colonies selected in 500 g of
kanamycin per ml were screened by PCR using the
cp32SK12NdeI primers (Table 1) that flank the site into which
the kan cassette had been inserted (Fig. 2A and B). Partial
sequence obtained from the fragment of phage DNA (data not
TABLE 3. Amplification of the VR1s of CA-11.2A,
B31, and BB-1a

a

TABLE 2. Predicted fragment sizes of VR1 of the B31 cp32s
B. burgdorferi
B31 plasmid

Size (bp)

Amplicon size
(bp)

cp32-1 ................................................................................... 3429
cp32-3 ................................................................................... 2442
cp32-4 ................................................................................... 3377
cp32-6 ................................................................................... 2507
cp32-7 ................................................................................... 3575
cp32-8 ................................................................................... 3429
cp32-9 ................................................................................... 3367
1p56 ...................................................................................... 2796
a
As determined by MacVector software using GenBank accession numbers AE001575, AE001576, AE001577, AE001578, AE001579, AE001580,
AE001581, and AE001584. Black arrows and hatched arrows indicate two pairs
of VR1s that are indistinguishable by our methods.

CA-11.2A
Total DNA

Predicted
B31 plasmid

B31-UM

Phage DNA

3,047
2,819
2,537

3,047

2,455

2,455

2,537

Total DNA

Phage DNA

3,426
3,343

3,426
3,343

2,828
2,484b

cp32-1 or 8
cp32-9 or 4
1p56

2,484

cp32-3b

a
Sizes determined by regression using Multi-Analyst software; predictions
based on size estimates from ⱖ3 trials and applicable only to the B31 fragments.
b
Prediction confirmed by sequencing of VR1.
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g of kanamycin per ml. We screened 10 of ⬃100 colonies by
PCR. All the colonies screened contained the kan gene integrated into a cp32 (Fig. 6A and data not shown).
The frequency of transduction of BB-1 between CA-11.2A
cells is ⬃10⫺5 to 10⫺6 per cell. Alternatively, the frequency of
transduction by BB-1 is ⬃10⫺7 per phage particle (⬃100
transductants from ⬃109 phage particles). No colonies grew
when either CA-11.2A cells without BB-1/kanR or BB-1/
kanR phage without cells were plated in kanamycin. The addition of proteinase K to BB-1/kanR prior to incubation with
cells abrogated the transduction of the antibiotic resistance
marker. Incubating washed, CHCl3-killed CA-11.2A/kanR cells

FIG. 3. Determining the minimum number of cp32 molecules in
B. burgdorferi cells and BB-1 capsids by PCR amplification of VR1.
Highly conserved primers that flank a variable region (VR1) of cp32
amplify four different size products from B. burgdorferi strains CA11.2A and B31. The two VR1s from the cp32s of B31 at ⬃3.3 kb can
be resolved with extended electrophoresis times (see Fig. 7). PCR of
BB-1 released from both of these strains amplifies three of the VR1
products (lanes 2 and 4), but not the ⬃2.8-kb amplicon (black arrow;
see Table 2). Fragments were resolved on a 0.8% agarose gel by FIGE
and stained with EtBr. Molecular sizes (in kilobase pairs) are indicated.

shown) indicates that the kan gene was inserted into the PF50
paralog of cp32. The cp32SK12NdeI primers amplify a product
from both the recombined cp32 (⬃1.4 kb) and the other homologous cp32 loci in the cells that do not contain the insert
(⬃100 bp) (Fig. 2B). Both products are expected in a population of B. burgdorferi cells containing more than one cp32 if, as
anticipated, the fragment bearing the kan cassette does not
recombine with all of the cp32s. The BB-1 capsids collected
from the supernatants of these CA-11.2A transformants include genomes containing the kan gene as well as uninserted
parental phage genomes (Fig. 2C). These data are consistent
with the results from the variable-region analysis, indicating
that more than one cp32 is packaged in a population of BB-1
phage heads (Fig. 3, lanes 2 and 4).
The genomic location of the integrated kan cassette was
determined by Southern hybridization (Fig. 4B and C) of total
DNA resolved by two-dimensional electrophoresis (Fig. 4A).
The blot of the gel was probed with cp32-specific probe 4 to
localize the circular 32-kb molecules (Fig. 4B). The membrane
was also probed with pOK12, the original source of the kanamycin resistance gene (4, 39) (Fig. 4C). pOK12 (the kan probe)
hybridizes only to the CA-11.2A/kanR transformant (Fig. 4C)
and has the same hybridization pattern as the cp32-specific
probe 4 (Fig. 4B), locating the integration site of the kan
cassette to a cp32. Extracted phage DNA (Fig. 5A) was also
analyzed. Probe 4 (Fig. 5B) hybridizes to phage DNA released
from both the parental and the transformed CA-11.2A; however, the kan cassette probe hybridizes to only the BB-1 DNA
packaged and released by CA-11.2A/kanR (Fig. 5C).
Transduction. To evaluate the ability of BB-1 to transduce
the kan gene into kanamycin-susceptible cells, bacteriophage
from the CA-11.2A/kanR transformant were incubated with
CA-11.2A cells at an approximately 100:1 multiplicity of infection. After an overnight incubation, the cells were plated in 500

FIG. 4. Analysis of the genomic location of the kanamycin resistance cassette. Total DNA from both parental CA-11.2A (P) and a
transformed clone of CA-11.2A/kanR (Tf) was extracted and resolved
by two-dimensional gel electrophoresis. The gel was stained with EtBr
(A), blotted to nylon, and probed with the cp32-specific probe 4 (B) or
pOK12, the source of the kan gene (C). The kan probe has the same
hybridization pattern as the cp32-specific probe. The supercoiled form
of cp32 is indicated by the black arrow, while the other hybridization
sites likely represent the nicked (or lp56) and linearized forms of cp32
generated during DNA isolation. Molecular sizes (in kilobase pairs)
are indicated.
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FIG. 5. Analysis of kan cassette packaging by BB-1. Phage particles were precipitated from both parental (P) and transformed (Tf)
CA-11.2A cells. The DNA was extracted and resolved on a 0.5%
agarose gel by conventional field electrophoresis. The gel was stained
with EtBr (A), then blotted and probed with either probe 4 (cp32specific; B) or pOK12 (kan; C). Molecular sizes (in kilobase pairs) are
indicated.

with live CA-11.2A cells resulted in 0 to 3 colonies. However,
no colonies grew when proteinase K was added to the dead
transformant cells prior to mixing them with susceptible cells,
implying that even the small amount of transfer between dead
CA-11.2A/kanR cells and live CA-11.2A cells requires protein.
These data indicate that phage BB-1 mediated the lateral
gene transfer.
BB-1/kanR isolated from the CA-11.2A transductant (CA11.2A/TR3) was incubated with several other strains of B. burgdorferi. The kan cassette was transduced by BB-1/kanR (CA11.2A) into B. burgdorferi strains B31 and 1A7 (a high-passage
clone of B. burgdorferi Sh2–82) (Fig. 6A). No demonstrable
DNA transfer occurred when dead CA-11.2A/kanR cells were
incubated with 1A7 and B31 cells. Long-range PCR using an
internal kan primer (KanR1207F) and the cp32-VR1R primer,
which lies outside the cloned fragment approximately 7.5 kb
from the insertion site, was done to verify the integration of the
kan cassette into the cp32 molecule (Fig. 6B). A partial sequence of the ospC gene from the transductant B31/TR1 confirmed that the strain (or at least the cp26) was derived from
B31 (data not shown).
The frequency of transduction by BB-1/kanR (CA-11.2A)
into B31 is ⬃10⫺6 to 10⫺7 and into 1A7 is ⬃10⫺5 to 10⫺6 for
individual clones of these strains. Neither the 1A7 transductant
(1A7/TR5) nor the B31 transductant (B31/TR1) assumes the
prolific CA-11.2A phage-producing phenotype, although both
B31 and B31/TR1 spontaneously produce low levels of BB-1.
BB-1 (B31) is also capable of packaging the kan cassette from
B31/TR1 (data not shown). The kan marker can be efficiently
transduced back into naive B31 using BB-1/kanR (B31), but
we have not yet been able to transduce the gene back into
susceptible CA-11.2A cells using BB-1/kanR (B31).
Variable-region analysis of the transduced cp32s. We have
demonstrated a mechanism for lateral gene transfer in B. burgdorferi via transduction by BB-1. To analyze possible changes
in the cp32 population of the transductants, the VR1s of the
uncloned parent strains CA-11.2A, B31, and 1A7, as well as the
transduced clones CA-11.2A/TR3, B31/TR1, and 1A7/TR5,
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were amplified and resolved by FIGE (Fig. 7A). The region of
the cp32 that we have designated VR1 is located ⬃5 kb from
the site of the kan insertion (7).
The fragments generated by PCR from the VR1 regions of
the CA-11.2A transductant (TR3; Fig. 7A, lane 2) are identical
to those of parental CA-11.2A (Fig. 7A, lane 1). The B31
transductant (TR1; Fig. 7A, lane 4) has lost the smallest VR1
(2,484 bp; corresponding to cp32–3) of the parental B31 (Fig.
7A, lane 3) and has gained a VR1 that is the same size as the
second smallest CA-11.2A VR1 (2,537 bp; Fig. 7A, black arrow). The B31 transductant has also lost the VR1 corresponding to lp56 (2,828 bp). In addition, 1A7 has a small VR1 (2,373
bp; Fig. 7A, lane 5) that is missing from 1A7/TR5 (Fig. 7A,
lane 6), and the transductant has gained a VR1 that is also the
same size as the second smallest CA-11.2A VR1 (2,537 bp; Fig.
7A, black arrow). This analysis suggests that the VR1 from the
introduced cp32, which contains the 2,537-bp VR1 (data not
shown), has replaced the smallest VR1 fragment of both B31/
TR1 and 1A7/TR5.
Whether the loss of the VR1 from the transductants is due
to displacement of a resident plasmid, recombination by the
kan gene into an extant plasmid, or the loss of a plasmid during

FIG. 6. PCR analysis of kanamycin-resistant transductants of
B. burgdorferi. (A) Putative transductants from B. burgdorferi strains
CA-11.2A, B31, and 1A7 were screened by PCR using the KanR1207F
and cp32SK12NdeIF primers. pCE210 was amplified as a positive
control (⫹), while the parental cells (P) of each strain served as
negative controls (lanes 1, 4, and 6). Lane 2 is the CA-11.2A/kanR
transformant (Tf). PCR yields a ⬃125-bp product from DNA containing the kan cassette (black arrow, lanes 2, 3, 5, and 7). The products
were resolved on a 1% agarose gel and stained by EtBr. (B) The kan
integration site in each transductant was verified by long-range PCR
using the KanR1207F and cp32-VR1R primers.
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FIG. 7. Amplification of variable region VR1 from B. burgdorferi
kan transductants. The cp32-VR1 primers were used to amplify the
cp32 VR1s of parental CA-11.2A (lane 1), B31 (lane 3), and 1A7 (lane
5) as well as transductants CA-11.2A/TR3 (lane 2), B31/TR1 (lane 4),
and 1A7/TR5 (lane 6). The 2,537-bp VR1 (black arrow) was found in
all transductants. Amplification products were resolved on 0.8% agarose gels by FIGE and stained with EtBr. Molecular sizes are shown in
kilobase pairs.

cloning and subsequent replacement with the BB-1/kanR
(CA-11.2A) prophage is not known. We have confirmed that
the 2,537-bp VR1 is linked to the kan cassette on the transduced BB-1/kanR (CA-11.2A) genome by amplifying the
VR1 region from the kanR/cp32-VR1R long-range PCR product (Fig. 6B and data not shown).
Restriction mapping of transductants. Plasmid DNA from
CA-11.2A, CA-11.2A/kanR (transformant), and CA-11.2A/
TR3 (transductant) was extracted and digested with EcoRV to
analyze changes in the restriction pattern of the cp32 molecules. The location of the kan cassette on cp32 was mapped
using Southern hybridization (Fig. 8A).
There are four hybridization sites in the cellular cp32
population digested with EcoRV and probed with the
cp32SK12NdeI probe (Fig. 8A, left panel). This includes a
⬃6.6-kb band (hatched arrow) in the parental CA-11.2A (Fig.
8A, lane 1). This EcoRV fragment is not present in either the
CA-11.2A/kanR transformant (Fig. 8A, lane 2) or the transductant, CA-11.2A/TR3 (Fig. 8A, lane 3). In the latter two strains,
there is a ⬃8-kb fragment (Fig. 8A, black arrow) that is not
found in the parental strain. The size difference is the same size
as the kan cassette (⬃1.3 kb), suggesting that the kan cassette
has been inserted into the 6.6-kb fragment. When the same
blot is probed with the kan marker, the ⬃8-kb fragments in the
CA-11.2A/kanR transformant and in CA-11.2A/TR3 are the
only hybridization sites (Fig. 8A, right panel, lanes 2 and 3,
respectively). The ⬃6.6-kb fragment also corresponds to the
major band in an EcoRV digest of BB-1 DNA probed with
the cp32SK12NdeI probe (data not shown).
To compare the kan insertion site in the other transductants,
plasmid DNA was extracted from parental CA-11.2A, B31, and
1A7 and the transductant CA-11.2A/TR3, B31/TR1, and 1A7/
TR5 cells. The plasmids were digested with XbaI, and the
DNA was resolved by FIGE. A blot of the gel was probed with
both the cp32SK12NdeI PCR product and the kan cassette
(Fig. 8B). When probed with the cp32SK12NdeI product (Fig.
8B, left panel), there is hybridization to a ⬃6.6-kb XbaI frag-

FIG. 8. Restriction mapping of the cp32s of B. burgdorferi kan
transductants. (A) Comparison of the restriction maps of parental,
transformant, and transductant CA-11.2A DNA. Plasmid DNA was
extracted from CA-11.2A (lane 1; P), the CA-11.2A/kanR transformant
(lane 2; Tf), and CA-11.2A/TR3 (lane 3; Td), digested with EcoRV,
and resolved by FIGE. A blot of the gel was probed either with the
cp32SK12NdeI PCR product (left panel) or with kan (right panel). A
unique ⬃6.6-kb fragment of CA-11.2A parental DNA is indicated by
the hatched arrow. A ⬃8-kb band (black arrow) corresponding to the
⬃6.6-kb band plus the 1.3-kb kan insert is present in both the transformant and the transductant. (B) Comparison of the restriction maps
of the cp32s of B. burgdorferi kan transductants. Plasmid DNA from
CA-11.2A (lane 1), CA-11.2A/TR3 (lane 2), B31 (lane 3), B31/TR1
(lane 4), 1A7 (lane 5), and 1A7/TR5 (lane 6) was digested with XbaI
and resolved by FIGE. A blot of the gel was probed with either the
cp32SK12NdeI probe (left panel) or the kan probe (right panel). A
⬃8-kb band (black arrow) is found only in the transductants. The
hatched arrow indicates the 6.6-kb fragment from the parental CA11.2A strain (lacking the kan cassette). Three bands (ⴱ) appear in
parental B31 but not B31/TR1. Molecular sizes are shown in kilobase
pairs.
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ment that is found exclusively in the parental CA-11.2A (Fig.
8B, lane 1; hatched arrow) and not in the parental B31 or 1A7.
However, a ⬃8-kb fragment is present in all the transductant
lanes (Fig. 8B, lanes 2, 4, and 6, black arrow). Hybridization
with kan (Fig. 8B, right panel) verified that the ⬃8-kb fragment
contained the kan cassette in all three transductants. This
suggests that the kan cassette is on a cp32 in the transductants
that is not a member of either of the parental B31 or 1A7
populations. The B31 parent has three bands that do not appear in B31/TR1 (Fig. 8B, left panel, lanes 3 and 4, asterisk),
possibly due either to displacement of a cp32 or loss of plasmids (cp32 or lp56) during cloning. There are also three bands
that are present in the B31 parent but absent from the transductant when plasmid DNA from these isolates is digested with
EcoRV and probed with the cp32SK12NdeI probe (data not
shown).
DISCUSSION
We recently identified BB-1, a temperate bacteriophage of
B. burgdorferi (Fig. 1), whose prophage is in the cp32 family of
circular plasmids (10–12). In this study we demonstrated that
BB-1 can package all of the free cp32s within a population of
cells (Fig. 3). To date, no known strain of B. burgdorferi carries
fewer than three cp32s (7, 8, 26), and any or all of these cp32s
may be prophages (associated with all of the necessary functions for lysogeny, progeny formation, and cellular lysis), or
perhaps cryptic prophages, requiring other factors in trans for
the successful propagation of BB-1. The effect that the protein products of the various cp32s (such as repressors) may
have on each other in trans has not been studied.
Prior to this work, no mechanism for lateral gene transfer
had been demonstrated in Borrelia. Previous evidence of recombination in at least one locus (erp, containing the ospE,
ospF, and elp homologs) on the cp32s (33, 38) suggested that
lateral gene transfer has occurred among these plasmids. Gene
transfer could be between different cp32s within the same cell,
by phage transduction of alternate cp32s within a population of
cells, or by some other, as yet undefined, mechanism. In this
study, the kan cassette was inserted into a fragment of phage
DNA and electroporated into CA-11.2A cells, generating a
recombinant cp32. To our knowledge, this is the first such
integration into a member of the cp32 plasmid family.
Mapping and sequence data (not shown) indicate that the
site of the kan cassette insertion is within the cp32–3 PF50
paralog (BBS34) of a CA-11.2A cp32, located near the variable
region that includes the putative paralogous partitioning genes
of the cp32s (7, 8, 36, 41). The cp32 containing the kan gene is
stable over 20 passages (⬃150 generations) in the absence of
selection, suggesting that the disrupted open reading frame
(ORF) (BBS34 homolog) either has no critical role in the
molecular metabolism of this plasmid or has a function that
can be supplied in trans by another cellular cp32. The PF50
paralog (BBC02) of the 9-kb circular plasmid (cp9), a derivative of cp32, is critical for the replication of a cp9-based vector
(37), suggesting that the replication requirements for this
smaller plasmid are different than those of the cp32s.
We have demonstrated transduction of the kan cassette by
BB-1 into three different strains of B. burgdorferi (Fig. 6–8).
This represents the first direct evidence of lateral gene transfer
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in B. burgdorferi. The ability of BB-1 to transduce the antibiotic resistance marker into a strain is apparently unrelated to
the ability of that strain to produce phage, since we have found
that both low-passage B31 and high-passage 1A7 are transducible but not inducible (12; data not shown). Additionally, introducing the BB-1/kanR (CA-11.2A) into these transducible
strains does not confer the phage-producing phenotype of CA11.2A on these strains.
The evidence suggests that the BB-1/kanR genome is being
introduced as a discrete plasmid into the cell during transduction. The host cell loses a VR1 marker concomitantly with
gaining the BB-1 (CA-11.2A) VR1, suggesting the displacement of a host plasmid (Fig. 7). However, there are no obvious
candidates discernible from the restriction maps (Fig. 8B). The
PF50 paralog into which the kan cassette has been inserted is
most similar to the PF50 paralog on cp32–3 of B31, the plasmid
that is apparently absent in the transductant as determined by
VR1 analysis. We hypothesize that the transduced cp32/kanR
from CA-11.2A phage displaced the resident cp32 homologs
(carrying the smallest VR1s) in strains B31 and 1A7 (no cp32
data are currently available for the 1A7 parental strain Sh2–
82). An alternate hypothesis is that prior loss of these cp32
homologs created populations of cells that were susceptible to
transduction. B31 cp32–3 can be lost during cloning, and the
loss of this plasmid has little or no effect on the infectivity of
this isolate (26). Analysis of the plasmid profiles of several
recent clones of CA-11.2A, B31, and 1A7 by PCR amplification of the VR1s suggests that the prior absence of the smallest
VR1 is not required for transduction to occur, particularly in
strain 1A7 (C. H. Eggers, B. J. Kimmel, and D. S. Samuels,
unpublished data).
In this study, we have demonstrated a mechanism for lateral
gene transfer that should be explored to establish its role
within the infectious cycle or during the course of disease.
Further analysis of BB-1, the first bacteriophage of B. burgdorferi described at a molecular level, could play a critical role
in the investigation of plasmid genetics, the development of a
genetic system, and the analysis of metabolic processes in these
bacteria as a whole.
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